DGFT eases Policy Conditions on Cough Syrup Exports to USA, UK, Canada, EU, Japan, Australia, Singapore, Republic of Korea and Switzerland

The Directorate General of Foreign Trade (DGFT) has eased policy conditions on the export of cough syrup to the USA, UK, Canada, EU, Japan, Australia, Singapore, Republic of Korea, and Switzerland. This change, effective immediately, aims to facilitate smoother export processes for pharmaceutical companies. The amendment removes certain restrictions previously imposed on the export of cough syrup, allowing exporters to meet international demand more efficiently. This decision is part of the government’s broader efforts to promote pharmaceutical exports and support the industry’s growth. By easing these policy conditions, the DGFT aims to enhance the competitiveness of Indian pharmaceutical companies in the global market. The notification reflects the government’s commitment to supporting the pharmaceutical sector and ensuring that regulatory frameworks are conducive to international trade.